FI20022159A0 - Nya farmaceutiska föreningar - Google Patents
Nya farmaceutiska föreningarInfo
- Publication number
- FI20022159A0 FI20022159A0 FI20022159A FI20022159A FI20022159A0 FI 20022159 A0 FI20022159 A0 FI 20022159A0 FI 20022159 A FI20022159 A FI 20022159A FI 20022159 A FI20022159 A FI 20022159A FI 20022159 A0 FI20022159 A0 FI 20022159A0
- Authority
- FI
- Finland
- Prior art keywords
- unsubstituted
- substituted
- prodrug forms
- methods
- pharmaceutical compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (28)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20022159A FI20022159A0 (sv) | 2002-12-05 | 2002-12-05 | Nya farmaceutiska föreningar |
EP03812203A EP1572198B1 (en) | 2002-12-05 | 2003-12-05 | New pharmaceutical compounds with alpha2receptor activity |
AU2003302622A AU2003302622B2 (en) | 2002-12-05 | 2003-12-05 | Imidazol derivatives having affinity for alpha 2 receptors activity |
MEP-2008-864A ME00521B (me) | 2002-12-05 | 2003-12-05 | Derivati imidazola sa afinitetom prema aktivnosti alfa 2 receptora |
YU20050428A RS52571B (en) | 2002-12-05 | 2003-12-05 | IMIDAZOLE DERIVATIVES WITH AFFINITY AFTER THE ACTIVITY OF ALPHA 2 RECEPTORS |
DE60304741T DE60304741T2 (de) | 2002-12-05 | 2003-12-05 | Neue pharmazeutische verbindungen mit alpha2receptor aktivität |
PT03812203T PT1572198E (pt) | 2002-12-05 | 2003-12-05 | Novos compostos farmaceuticos com actividade de receptor alfa2. |
NZ540466A NZ540466A (en) | 2002-12-05 | 2003-12-05 | Imidazole derivatives having affinity for alpha 2 receptors activity |
PCT/FI2003/000933 WO2004050635A2 (en) | 2002-12-05 | 2003-12-05 | Imidazol derivatives having affinity for alpha 2 receptors activity |
SI200330300T SI1572198T1 (sl) | 2002-12-05 | 2003-12-05 | Nove farmacevtske spojine z alfa2 receptorsko aktivnostjo |
AT03812203T ATE323484T1 (de) | 2002-12-05 | 2003-12-05 | Neue pharmazeutische verbindungen mit alpha2receptor aktivität |
JP2004556387A JP4667042B2 (ja) | 2002-12-05 | 2003-12-05 | 新規医薬化合物 |
EA200500922A EA008251B1 (ru) | 2002-12-05 | 2003-12-05 | Производные имидазола, обладающие аффиностью по отношению к альфарецепторам |
CA2508335A CA2508335C (en) | 2002-12-05 | 2003-12-05 | Imidazole derivatives having affinity for alpha 2 receptors activity |
KR1020057009983A KR20050114603A (ko) | 2002-12-05 | 2003-12-05 | 신규 약학적 화합물 |
BR0317024-1A BR0317024A (pt) | 2002-12-05 | 2003-12-05 | Derivados de imidazol que têm afinidade pela atividade dos receptores alfa 2 |
DK03812203T DK1572198T3 (da) | 2002-12-05 | 2003-12-05 | Farmaceutiske forbindelser med alfa2-receptoraktivitet |
MXPA05005963A MXPA05005963A (es) | 2002-12-05 | 2003-12-05 | Derivados de imidazol que tienen afinidad hacia la actividad de los receptores alfa-2. |
ES03812203T ES2262031T3 (es) | 2002-12-05 | 2003-12-05 | Nuevos compuestos farmaceuticos con actividad receptora alpha2. |
US10/537,622 US7759496B2 (en) | 2002-12-05 | 2003-12-05 | Imidazole derivatives having affinity for alpha 2 receptors activity |
CNB2003801051320A CN100560070C (zh) | 2002-12-05 | 2003-12-05 | 具有α2受体亲和活性的咪唑衍生物 |
PL377530A PL216530B1 (pl) | 2002-12-05 | 2003-12-05 | Estry alkilowe 4-(6-hydroksyindan-1-ylometylo)-1H-imidazolu, ich zastosowanie oraz zawierające je kompozycje farmaceutyczne |
IL168882A IL168882A (en) | 2002-12-05 | 2005-05-30 | Imidazole derivatives having affinity for alpha 2 receptor activity |
ZA200504533A ZA200504533B (en) | 2002-12-05 | 2005-06-02 | Imidazol derivatives having affinity for alpha 2 receptors activity. |
IS7911A IS2282B (is) | 2002-12-05 | 2005-06-23 | Ný lyfefnasambönd með alfa2viðtakavirkni |
HRP20050617AA HRP20050617B1 (hr) | 2002-12-05 | 2005-07-04 | Derivati imidazola s afinitetom prema aktivnosti alfa 2 receptora |
NO20053302A NO330392B1 (no) | 2002-12-05 | 2005-07-05 | Imidazolderivater med affinitet for alfa 2-reseptoraktivitet og anvendelser derav, samt farmasoytisk preparat omfattende imidazolderivat |
CY20061100913T CY1105699T1 (el) | 2002-12-05 | 2006-07-03 | Νεες φαρμακευτικες ενωσεις με αλφα2υποδοχεα δραστηριοτητας |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20022159A FI20022159A0 (sv) | 2002-12-05 | 2002-12-05 | Nya farmaceutiska föreningar |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20022159A0 true FI20022159A0 (sv) | 2002-12-05 |
Family
ID=8565048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20022159A FI20022159A0 (sv) | 2002-12-05 | 2002-12-05 | Nya farmaceutiska föreningar |
Country Status (27)
Country | Link |
---|---|
US (1) | US7759496B2 (sv) |
EP (1) | EP1572198B1 (sv) |
JP (1) | JP4667042B2 (sv) |
KR (1) | KR20050114603A (sv) |
CN (1) | CN100560070C (sv) |
AT (1) | ATE323484T1 (sv) |
BR (1) | BR0317024A (sv) |
CA (1) | CA2508335C (sv) |
CY (1) | CY1105699T1 (sv) |
DE (1) | DE60304741T2 (sv) |
DK (1) | DK1572198T3 (sv) |
EA (1) | EA008251B1 (sv) |
ES (1) | ES2262031T3 (sv) |
FI (1) | FI20022159A0 (sv) |
HR (1) | HRP20050617B1 (sv) |
IL (1) | IL168882A (sv) |
IS (1) | IS2282B (sv) |
ME (1) | ME00521B (sv) |
MX (1) | MXPA05005963A (sv) |
NO (1) | NO330392B1 (sv) |
NZ (1) | NZ540466A (sv) |
PL (1) | PL216530B1 (sv) |
PT (1) | PT1572198E (sv) |
RS (1) | RS52571B (sv) |
SI (1) | SI1572198T1 (sv) |
WO (1) | WO2004050635A2 (sv) |
ZA (1) | ZA200504533B (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8003624B2 (en) | 2005-08-25 | 2011-08-23 | Schering Corporation | Functionally selective ALPHA2C adrenoreceptor agonists |
WO2007024949A2 (en) | 2005-08-25 | 2007-03-01 | Schering Corporation | Alpha2c adrenoreceptor agonists |
US7700592B2 (en) | 2005-08-25 | 2010-04-20 | Schering Corporation | α2C adrenoreceptor agonists |
TW201026691A (en) | 2008-10-07 | 2010-07-16 | Schering Corp | Biaryl spiroaminooxazoline analogues as alpha2C adrenergic receptor modulators |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4673679A (en) * | 1986-05-14 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration |
GB9425211D0 (en) * | 1994-12-14 | 1995-02-15 | Ucb Sa | Substituted 1H-imidazoles |
GB9520150D0 (en) | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
JPH10195056A (ja) * | 1996-11-12 | 1998-07-28 | Takeda Chem Ind Ltd | 縮合ベンゼン誘導体、その製造法および剤 |
EA003216B1 (ru) | 1998-09-28 | 2003-02-27 | Орион Корпорейшн | Применение 3-(1h-имидазол-4-илметил)индан-5-ола при изготовлении лекарственного средства для интраспинального, подоболочечного или эпидурального введения |
WO2001030347A1 (en) * | 1999-10-29 | 2001-05-03 | Orion Corporation | Treatment or prevention of hypotension and shock |
US6388090B2 (en) * | 2000-01-14 | 2002-05-14 | Orion Corporation | Imidazole derivatives |
FI20000073A0 (sv) * | 2000-01-14 | 2000-01-14 | Orion Yhtymae Oy | Nya imidazol derivat |
US7091232B2 (en) | 2002-05-21 | 2006-08-15 | Allergan, Inc. | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
US7439268B2 (en) * | 2003-07-18 | 2008-10-21 | Idexx Laboratories | Compositions containing prodrugs of florfenicol and methods of use |
-
2002
- 2002-12-05 FI FI20022159A patent/FI20022159A0/sv unknown
-
2003
- 2003-12-05 NZ NZ540466A patent/NZ540466A/en not_active IP Right Cessation
- 2003-12-05 US US10/537,622 patent/US7759496B2/en active Active
- 2003-12-05 DE DE60304741T patent/DE60304741T2/de not_active Expired - Lifetime
- 2003-12-05 SI SI200330300T patent/SI1572198T1/sl unknown
- 2003-12-05 ES ES03812203T patent/ES2262031T3/es not_active Expired - Lifetime
- 2003-12-05 CA CA2508335A patent/CA2508335C/en not_active Expired - Lifetime
- 2003-12-05 ME MEP-2008-864A patent/ME00521B/me unknown
- 2003-12-05 RS YU20050428A patent/RS52571B/en unknown
- 2003-12-05 PT PT03812203T patent/PT1572198E/pt unknown
- 2003-12-05 EP EP03812203A patent/EP1572198B1/en not_active Expired - Lifetime
- 2003-12-05 BR BR0317024-1A patent/BR0317024A/pt unknown
- 2003-12-05 MX MXPA05005963A patent/MXPA05005963A/es active IP Right Grant
- 2003-12-05 WO PCT/FI2003/000933 patent/WO2004050635A2/en active IP Right Grant
- 2003-12-05 EA EA200500922A patent/EA008251B1/ru not_active IP Right Cessation
- 2003-12-05 PL PL377530A patent/PL216530B1/pl unknown
- 2003-12-05 CN CNB2003801051320A patent/CN100560070C/zh not_active Expired - Lifetime
- 2003-12-05 JP JP2004556387A patent/JP4667042B2/ja not_active Expired - Fee Related
- 2003-12-05 KR KR1020057009983A patent/KR20050114603A/ko active Search and Examination
- 2003-12-05 AT AT03812203T patent/ATE323484T1/de active
- 2003-12-05 DK DK03812203T patent/DK1572198T3/da active
-
2005
- 2005-05-30 IL IL168882A patent/IL168882A/en not_active IP Right Cessation
- 2005-06-02 ZA ZA200504533A patent/ZA200504533B/en unknown
- 2005-06-23 IS IS7911A patent/IS2282B/is unknown
- 2005-07-04 HR HRP20050617AA patent/HRP20050617B1/hr not_active IP Right Cessation
- 2005-07-05 NO NO20053302A patent/NO330392B1/no not_active IP Right Cessation
-
2006
- 2006-07-03 CY CY20061100913T patent/CY1105699T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE556058T1 (de) | 1-(2h)-isochinolonderivat | |
DK1261602T3 (da) | Imidazol-2-carboxamidderivater som Raf-kinaseinhibitorer | |
NO20062269L (no) | Pyridin-karboksylsyrederivater som glucokinasemodulatorer | |
DE60315265D1 (de) | Stickstoffhaltige heterocyclische verbindung und arzneimittel davon | |
AR019263A1 (es) | Compuestos derivados de hidroxamida del acido (4-arilsulfonilamino) tetrahidropiran-4-carboxilico, composiciones farmaceuticas y metodos de tratamiento. | |
WO2008114819A1 (ja) | 新規アデニン化合物 | |
NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
DK1178967T3 (da) | Quinolinderivater som inhibitorer af MEK-enzymer | |
IL161559A0 (en) | Dibenzylamine derivatives and pharmaceutical compositions containing the same | |
AR023152A1 (es) | Compuesto tienopirimidina, procedimiento para producirlo, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar dichacomposicion | |
ME00981B (me) | 1,2,4,5-tetrahidr0-3h-benzazepinska jedinjenja, postupak za njihovu izradu i smješe koje ih sadrže | |
AU2001235838A1 (en) | Imidazol derivatives as raf kinase inhibitors | |
NO20054092L (no) | Nye tricykliske azepinforbindelser, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
IS2282B (is) | Ný lyfefnasambönd með alfa2viðtakavirkni | |
EA200600551A1 (ru) | Соединения пиперазина, способ их получения и фармацевтические композиции, которые их содержат | |
RS54061B1 (en) | QUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONCERNING THEM, AND THEIR APPLICATIONS | |
EA200001248A1 (ru) | Новые линейные и циклические производные мочевины, способ их получения и их содержащие фармацевтические композиции | |
EA200500028A1 (ru) | Новые соединения 3-(4-оксо-4h-хромен-2-ил)-(1h)-хинолин-4-она, способ их получения и фармацевтические композиции, которые их содержат | |
ATE401884T1 (de) | Arzneizusammensetzungen enthaltend oxapenem-3- carbonsäuren | |
NO20022891L (no) | Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem | |
HRPK20070123B3 (en) | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | |
ATE268769T1 (de) | Pyrimidinderivate mit antitumor-wirkung | |
ECSP993005A (es) | Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos | |
EA200200636A1 (ru) | Новые соединения 3-имино-1,2-дитиола, способ их получения и фармацевтические композиции, их содержащие |